• ENG

Why Do Some COVID-19 Patients Develop Life-Threatening Blood Clots? Scientists Explain

Why Do Some COVID-19 Patients Develop Life-Threatening Blood Clots? Scientists Explain
COVID-19 And Blood Clots: Scientists Reveal The Life Threatening Link

While COVID-19 infection is giving the whole world a tough battle to win, blood clotting in COVID patients are on the rise. Here is the reason why some patients are developing this life-threatening condition.

Written by Satata Karmakar |Updated : June 17, 2021 10:01 AM IST

In the recent past, several reports have surfaced wherein patients suffering from COVID-19 complained about blood clotting. What exactly leads to this fatal condition? To answer the question, Scientists in Ireland have identified how and why some COVID-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening.

Why Do Some COVID-19 Patients Develop Blood Clots?

The study, published in the 'Journal of Thrombosis and Haemostasis', was carried by researchers from the Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences. According to the researchers, the study found that the balance between a molecule that causes clotting, called von Willebrand Factor (VWF), and its regulator called ADAMTS13, is severely disrupted in patients with severe COVID-19.

Previous research has established that blood clotting is a significant cause of death in patients with COVID-19. "Our research helps provide insights into the mechanisms that cause severe blood clots in patients with COVID-19, which is critical to developing more effective treatments," said Dr. Jamie O'Sullivan, the study's corresponding author and research lecturer within the Irish Centre for Vascular Biology at RCSI. "While more research is needed to determine whether targets aimed at correcting the levels of ADAMTS13 and VWF may be a successful therapeutic intervention, it is important that we continue to develop therapies for patients with COVID-19. COVID-19 vaccines will continue to be unavailable to many people throughout the world, and it is important that we provide effective treatments to them and to those with breakthrough infections," he said.

Also Read

More News

How And Why Blood Clotting Happens In COVID Patients?

To understand why that clotting happens, the researchers analysed blood samples that were taken from patients with COVID-19 in the Beaumont Hospital Intensive Care Unit in Dublin. When compared to control groups, the blood of COVID-19 patients had higher levels of the pro-clotting VWF molecules and lower levels of the anti-clotting ADAMTS13. Furthermore, the researchers identified other changes in proteins that caused the reduction of ADAMTS13.

The study was funded by the Irish COVID-19 Vasculopathy Study (ICVS) through the Health Research Board COVID-19 Rapid Response award as well as a philanthropic grant from the 3M Foundation to RCSI University of Medicine and Health Sciences in support of COVID-19 research.

(With inputs from Agencies)